VIVO mapping Protocol

  • Research type

    Research Study

  • Full title

    VIVO™ non-invasive Time Assessment Protocol

  • IRAS ID

    257755

  • Contact name

    Sabine Ernst

  • Contact email

    S.Ernst@rbht.nhs.uk

  • Sponsor organisation

    Royal Brompton and Harefield NHS Foundation Trust (RB&HFT)

  • Duration of Study in the UK

    0 years, 10 months, 31 days

  • Research summary

    This is a single center study enrolling 15 subjects with structurally normal hearts that are already indicated for a ventricular ablation procedure (VT or PVCs).

    The purpose is to compare the accuracy of VIVO and to assess its efficacy to decrease procedural time, and ideally, the procedural overall costs, as compared to standard of care ablation procedures.

    Subjects will undergo a CT scan prior to the procedure, which will be used to create a personalized 3D model. This will be merged with a 3D photograph (taken at the start of the procedure) of the ECG electrodes on the subject’s torso. Then, the recording of the 12 lead ECG will be imported into the VIVO software. All of this data will be combined via the software and a mathematical algorithm will determine the origin of the arrhythmia. This will show the physician where to perform a successful ablation. After 3 months, the subject will return for follow up and receive another Holter monitor (ECG recording) to determine ablation success.

    Subjects will be exited from the study after the 3 month follow up visit. Patients will receive standard clinical care prior to, during and after their scheduled procedure, as well as after being discarded from the trial.

  • REC name

    London - Surrey Research Ethics Committee

  • REC reference

    19/LO/0308

  • Date of REC Opinion

    18 Apr 2019

  • REC opinion

    Further Information Favourable Opinion